Literature DB >> 1508227

Thyroid hormone alters in vitro DNA binding of monomers and dimers of thyroid hormone receptors.

R C Ribeiro1, P J Kushner, J W Apriletti, B L West, J D Baxter.   

Abstract

T3 binds to intranuclear thyroid hormone receptors (TRs) on target DNA elements and exerts profound influences on gene expression by mechanisms not yet characterized. We used gel shift assays and cross-linking experiments to demonstrate that T3 greatly induced the monomeric binding of the hTR beta produced in Escherichia coli to DNA. T3 also increased the gel mobility of these monomer-DNA complexes suggesting they undergo a ligand-induced conformational change. This effect did not depend on the orientation and spacing of the half-site motifs within the DNA structure. In contrast, T3 had diverse effects on the dimeric interaction. T3 increased the dimeric interaction to the palindrome GGTCA.TGACC (an effect lost by spacing the half-sites with 3 base pairs) and decreased the dimeric interaction to the inverted palindrome containing the TGACC.GGTCA motif. Scatchard analyses indicated that the T3 enhancement on binding was due to an increase in the number of TR with high affinity DNA-binding activity and not by increasing the affinity of TR that could bind to DNA. The effects of various T3 analogs were directly related to their affinities for the TR. These ligand effects on in vitro TR-DNA binding may reflect mechanisms by which T3 regulates transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508227     DOI: 10.1210/mend.6.7.1508227

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Structure of a thyroid hormone receptor DNA-binding domain homodimer bound to an inverted palindrome DNA response element.

Authors:  Yi Chen; Matthew A Young
Journal:  Mol Endocrinol       Date:  2010-07-07

2.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

Review 3.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

4.  Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.

Authors:  M Jeyakumar; Paul Webb; John D Baxter; Thomas S Scanlan; John A Katzenellenbogen
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

5.  DNA bending by the silencer protein NeP1 is modulated by TR and RXR.

Authors:  R Arnold; M Burcin; B Kaiser; M Muller; R Renkawitz
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

6.  DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR.

Authors:  K Shulemovich; D D Dimaculangan; D Katz; M A Lazar
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

7.  Dissecting the Relation between a nuclear receptor and GATA: binding affinity studies of thyroid hormone receptor and GATA2 on TSHβ promoter.

Authors:  Ana Carolina Migliorini Figueira; Igor Polikarpov; Dmitry Veprintsev; Guilherme Martins Santos
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

8.  The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.

Authors:  M Au-Fliegner; E Helmer; J Casanova; B M Raaka; H H Samuels
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.

Authors:  F X Claret; T Antakly; M Karin; F Saatcioglu
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

10.  Thyroid hormone receptor can modulate retinoic acid-mediated axis formation in frog embryogenesis.

Authors:  D E Banker; R N Eisenman
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.